[go: up one dir, main page]

GT199900074A - 3-ceto derivados tricìclicos de 6-0metileritromicina.- - Google Patents

3-ceto derivados tricìclicos de 6-0metileritromicina.-

Info

Publication number
GT199900074A
GT199900074A GT199900074A GT199900074A GT199900074A GT 199900074 A GT199900074 A GT 199900074A GT 199900074 A GT199900074 A GT 199900074A GT 199900074 A GT199900074 A GT 199900074A GT 199900074 A GT199900074 A GT 199900074A
Authority
GT
Guatemala
Prior art keywords
methylerithromycine
ceto
tricyclic derivatives
those
present
Prior art date
Application number
GT199900074A
Other languages
English (en)
Inventor
Yong-Jin Wu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900074A publication Critical patent/GT199900074A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTA INVENCIÒN SE REFIERE A NUEVOS 3CETO DERIVADOS DE 60 METILERITROMICINA A [VER "FÒRMULA (I)]. LOS COMPUESTOS DE ÈSTA INVENCIÒN SON ÙTILES COMO AGENTES ANTIBIÒTICOS EN MAMÌFEROS, INCLUYENDO EL HOMBRE, ADEMÀS DE PECES Y AVES. LOS COMPUESTOS DE LA PRESENTE INVENCIÒN SON ANTIBIÒTICOS MACRÒLIDOS DE AMPLIO ESPECTRO QUE SON EFICACES CONTRA INFECCIONES PROVOCADAS POR CIERTAS VACTERIAS GRAMPOSITIVAS Y GRAMNEGATILVAS, ADEMÀS DE POR PROTOZOOS.
GT199900074A 1998-06-03 1999-06-28 3-ceto derivados tricìclicos de 6-0metileritromicina.- GT199900074A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8779898P 1998-06-03 1998-06-03

Publications (1)

Publication Number Publication Date
GT199900074A true GT199900074A (es) 2000-12-19

Family

ID=22207328

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900074A GT199900074A (es) 1998-06-03 1999-06-28 3-ceto derivados tricìclicos de 6-0metileritromicina.-

Country Status (10)

Country Link
US (1) US6248719B1 (es)
AP (1) AP9901559A0 (es)
AR (1) AR017488A1 (es)
AU (1) AU3439899A (es)
GT (1) GT199900074A (es)
HN (1) HN1999000082A (es)
MA (1) MA26639A1 (es)
PA (1) PA8474401A1 (es)
TN (1) TNSN99104A1 (es)
WO (1) WO1999062920A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
DE69908855T2 (de) * 1998-04-24 2004-05-19 Pfizer Products Inc., Groton 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
CA2373117C (en) 1999-05-24 2006-02-28 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
WO2006067589A1 (en) 2004-12-21 2006-06-29 Pfizer Products Inc. Macrolides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096915T3 (es) * 1992-04-22 1997-03-16 Taisho Pharmaceutical Co Ltd Derivado de 5-o-desosaminileritronolida a.
FR2732023B1 (fr) 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69631609T2 (de) * 1995-11-08 2005-01-05 Abbott Laboratories, Abbott Park Tricyclische erythromycinderivate
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos

Also Published As

Publication number Publication date
AP9901559A0 (en) 1999-06-30
MA26639A1 (fr) 2004-12-20
AR017488A1 (es) 2001-09-05
WO1999062920A1 (en) 1999-12-09
HN1999000082A (es) 1999-09-29
US6248719B1 (en) 2001-06-19
AU3439899A (en) 1999-12-20
PA8474401A1 (es) 2000-05-24
TNSN99104A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
GT199800077A (es) Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4" sustituidos.
ES2161220T3 (es) 9-((glicil sustituido)amido)-6-desmetil-6-desoxitetraciclinas como agentes antibioticos.
GT199800074A (es) Derivados de la 9-oxima eritromicina.
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
PA8461701A1 (es) Derivados de 9-amino-3-ceto eritromicina
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
ES2173876T3 (es) Nuevas 7-(sustituido)-8-(sustituido)-9-(amino sustituido)-6-desmetil-desoxitetraciclinas como agentes antibioticos.
ES2196072T3 (es) Empleo de compuestos heterociclicos como ligandos de dopamina-d3.
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
BR0111222A (pt) Derivados fosfonados de glicopeptìdeo
MX9304647A (es) 7-(sustituido)-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinas y metodo para su produccion.
DE69330852D1 (de) 7-(subtituierte)-8-(substituierte)-9-(substituiertes Glycyl)amido-6-demethyl-6-deoxytetracycline
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
PA8465901A1 (es) Nuevos derivados de la eritromicina
UY27026A1 (es) Derivados benzodiacepínicos como moduladores de los receptores gaba a
BR9916060A (pt) Triterpenos pentacìclicos
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
GT199800162A (es) Derivados de eritromicina triciclicos.
DE69910554D1 (de) Entzendungshemmende antibakterielle benzylphenolverbindungen
GT199900074A (es) 3-ceto derivados tricìclicos de 6-0metileritromicina.-
MX9306666A (es) Nuevas azetidinonas substituidas como agentes antiinflamatorios y antidegenerativos.
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
AU699488B2 (en) Novel peptide and therapeutic agent
DE69936052D1 (de) N1 modifizierte glycopeptide
ES2173586T3 (es) Derivados de ciclohexandiol.